ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CDTX Cidara Therapeutics Inc

14.506
4.26 (41.52%)
After Hours
Last Updated: 16:22:58
Delayed by 15 minutes

Period:

Draw Mode:

Volume 154,768
Bid Price 14.51
Ask Price 14.66
News -
Day High 12.59

Low
10.004

52 Week Range

High
29.60

Day Low 10.10
Company Name Stock Ticker Symbol Market Type
Cidara Therapeutics Inc CDTX NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
4.26 41.52% 14.506 16:22:58
Open Price Low Price High Price Close Price Prev Close
10.18 10.10 12.59 12.35 10.25
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,218 154,768 $ 11.10 $ 1,718,668 - 10.004 - 29.60
Last Trade Time Type Quantity Stock Price Currency
16:23:01 5 $ 14.66 USD

Cidara Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
1.05B 90.43M - 64.29M -29.8M -0.33 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Cidara Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CDTX Message Board. Create One! See More Posts on CDTX Message Board See More Message Board Posts

Historical CDTX Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.4616.0010.00410.881,348,0840.0460.32%
1 Month15.02624.4010.00417.181,330,307-0.52-3.46%
3 Months13.0024.4010.00415.85759,1031.5111.58%
6 Months16.82224.4010.00415.63682,262-2.32-13.77%
1 Year22.6029.6010.00418.99710,686-8.09-35.81%
3 Years44.2047.808.0024.64822,379-29.69-67.18%
5 Years46.2089.008.0031.50647,796-31.69-68.60%

Cidara Therapeutics Description

Cidara Therapeutics Inc is a biotechnology company. It is focused on the discovery, development, and commercialization of novel anti-infectives for the treatment and prevention of diseases. The company's Rezafungin is a novel molecule in the echinocandin class of antifungals. It is developing rezafungin for the first-line treatment and prevention of serious, invasive fungal infections which are associated with high mortality rates.

Your Recent History

Delayed Upgrade Clock